Phreesia, Inc.
NYSE:PHRMedical - Healthcare Information Services
+$0.08 today
- Market cap
- $760.99M
- Beta
- 0.88
- P/E (TTM)
- 62.6
- EPS (TTM)
- $0.15
Volume 0.86M
Average 1.97M
PHR Net Change in Cash
Combined operating, investing, financing, and currency effects on the cash balance during the period.
Phreesia, Inc.NYSE: PHR
Net Change in Cash · Q1 FY2027 · quarter ended Apr 2026
Net change in cash declines year over year
Q1 FY2027 net change in cash of $876K fell 86.8% year over year, ahead of the -242.5% change in trailing-twelve-month net change in cash. Over 3 fiscal years it compounded at -57.7% a year.
Context
- Net change in cash amounted to 2.2% of revenue in FY2026, up 1.4 pp from a year earlier.
- Net change in cash grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of -86.8% holds above the trailing-twelve-month pace of -242.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Net Change in Cash history
USD · from the cash flow
- Latest · FY2026
- (10.39M) USD
- Year-over-year change
- -214.8%
| Period | Period end | Net Change in Cash | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | (10.39M) | -214.8% |
| FY2025 | 2025-01-31 | (3.3M) | +96.3% |
| FY2024 | 2024-01-31 | (89.16M) | +35.0% |
| FY2023 | 2023-01-31 | (137.13M) | -244.3% |
| FY2022 | 2022-01-31 | 95.03M | — |
Net Change in Cash vs competitors
How PHR compares with its peers on the latest reported figures
- PHR's LTM Apr 2026 net change in cash of $16.17M is the 10th largest of the 11 companies compared; the peer median is $13.46M.
- Its year-over-year change of -242.5% is the 10th highest of 11, against a peer median of -40.4%.
- Net change in cash amounts to 3.3% of revenue for PHR, versus a peer median of 13.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $442.59M | -563.9% | — | 17.6% | |
| LTM Jan 2026 | $236.97M | +504.0% | — | 283.0% | |
| LTM Mar 2026 | $152.37M | +530.7% | — | 53.8% | |
| LTM Mar 2026 | $123.44M | -9.0% | +275.6% | 10.1% | |
| LTM Sep 2026 | $72.13M | +516.7% | — | 26.8% | |
| LTM Mar 2026 | $65.27M | -71.9% | +0.5% | 8.3% | |
| LTM Mar 2026 | $44.12M | -218.5% | +7.4% | 44.2% | |
| LTM Aug 2026 | $33.12M | +79.9% | -21.9% | 3.7% | |
| LTM Mar 2026 | $32.11M | -90.2% | -12.6% | 4.8% | |
| LTM Apr 2026 | $16.17M | -242.5% | -57.7% | 3.3% | |
| LTM Sep 2026 | $5.19M | -83.2% | — | 2.0% | |
| Peer median (excluding PHR) | $13.46M | -40.4% | +0.5% | 13.8% | |
Competitors are the stored peer set for PHR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | (118.16M) | (176.15M) | (136.89M) | (58.53M) | 2.31M |
| Depreciation & Amortization | 21.3M | 25.3M | 29.49M | 27.89M | 31.45M |
| Deferred Income Tax | 143K | 434K | 228K | 214K | (13.27M) |
| Stock-Based Compensation | 36.14M | 58.78M | 71.7M | 66.98M | 67.45M |
| Change in Working Capital | (18.57M) | (3.86M) | (1.64M) | (6.49M) | (14.09M) |
| Accounts Receivables | (10.22M) | (11.13M) | (11.21M) | (8.81M) | (10.15M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 2.88M | 4.77M | (1.99M) | (3.23M) | 5.26M |
| Other Working Capital | (11.24M) | 2.5M | 11.56M | 5.55M | (9.2M) |
| Other Non-Cash Items | 4.43M | 5.37M | 4.73M | 2.33M | 4.96M |
| Operating Cash Flow | (74.71M) | (90.12M) | (32.38M) | 32.38M | 78.81M |
| Capital Expenditures | (30.81M) | (26.2M) | (25.1M) | (24.09M) | (11.1M) |
| Acquisitions (Net) | (34.42M) | 0 | (14.57M) | 0 | (153.19M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 15.71M |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (12.39M) | (21.47M) | (19.29M) | (15.38M) | (13.3M) |
| Investing Cash Flow | (65.23M) | (26.2M) | (39.67M) | (24.09M) | (161.88M) |
| Debt Repayment | (4.27M) | (5.95M) | (6.78M) | (7.81M) | 83.18M |
| Common Stock Issued | 245.81M | 4.92M | 0 | 3.93M | 3.83M |
| Common Stock Repurchased | (9M) | (19.38M) | (12.18M) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.42M | (397K) | 1.84M | (7.61M) | (14.15M) |
| Financing Cash Flow | 234.97M | (20.8M) | (17.12M) | (11.49M) | 72.85M |
| Effect of Forex Changes | 0 | 0 | 0 | (106K) | (176K) |
| Net Change in Cash | 95.03M | (137.13M) | (89.16M) | (3.3M) | (10.39M) |
| Free Cash Flow | (105.52M) | (116.33M) | (57.48M) | 8.29M | 67.71M |
Phreesia, Inc.
NYSE:PHR
Intrinsic Alpha fair value
Locked
Current Price
$12.26
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.